Delayed processing of blood increases the frequency of activated CD11b+ CD15+ granulocytes which inhibit T cell function

Journal of Immunological Methods

Volumn 341, Issue 1-2, 2009, Pages 68-75

  McKenna, Kyle C ^a   Beatty, Kelly M ^a   Vicetti Miguel, Rodolfo ^b   Bilonick, Richard A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Blood processing; CD11b; CD15; Granulocytes; T cell inhibition; T cells

Indexed keywords

CD11B ANTIGEN; CD15 ANTIGEN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; PHYTOHEMAGGLUTININ;

ARTICLE; BLOOD ANALYSIS; BLOOD STORAGE; CELL ACTIVATION; CELL FUNCTION; CELL ISOLATION; CELL PROLIFERATION; CELL SELECTION; CONTROLLED STUDY; FREEZING; GRANULOCYTE; HUMAN; HUMAN CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; ROOM TEMPERATURE; T LYMPHOCYTE;

ANTIGENS, CD11B; ANTIGENS, CD15; ANTIGENS, CD3; BLOOD COMPONENT REMOVAL; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GRANULOCYTES; HUMANS; MALE; PRESERVATION, BIOLOGICAL; T-LYMPHOCYTES; TIME FACTORS;

EID: 59249095471     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2008.10.019     Document Type: Article

References (11)

1. Betensky R.A., Connick E., Devers J., Landay A.L., Nokta M., Plaeger S., Rosenblatt H., Schmitz J.L., Valentine F., Wara D., Weinberg A., and Lederman H.M. Shipment impairs lymphocyte proliferative responses to microbial antigens. Clin. Diagn. Lab Immunol. 7 (2000) 759
2. Bull M., Lee D., Stucky J., Chiu Y.L., Rubin A., Horton H., and McElrath M.J. Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials. J. Immunol. Methods 322 (2007) 57
3. Kaplan J., Nolan D., and Reed A. Altered lymphocyte markers and blastogenic responses associated with 24 hour delay in processing of blood samples. J. Immunol. Methods 50 (1982) 187
4. Kumar P., and Satchidanandam V. Ethyleneglycol-bis-(beta-aminoethylether)tetraacetate as a blood anticoagulant: preservation of antigen-presenting cell function and antigen-specific proliferative response of peripheral blood mononuclear cells from stored blood. Clin. Diagn. Lab. Immunol. 7 (2000) 578
5. Nicholson J.K., Jones B.M., Cross G.D., and McDougal J.S. Comparison of T and B cell analyses on fresh and aged blood. J. Immunol. Methods 73 (1984) 29
6. Rodriguez P.C., Quiceno D.G., and Ochoa A.C. L-arginine availability regulates T-lymphocyte cell-cycle progression. Blood 109 (2007) 1568
7. Schmielau J., and Finn O.J. Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients. Cancer Res. 61 (2001) 4756
8. Shenton D., Smirnova J.B., Selley J.N., Carroll K., Hubbard S.J., Pavitt G.D., Ashe M.P., and Grant C.M. Global translational responses to oxidative stress impact upon multiple levels of protein synthesis. J. Biol. Chem. 281 (2006) 29011
9. Zea A.H., Curti B.D., Longo D.L., Alvord W.G., Strobl S.L., Mizoguchi H., Creekmore S.P., O'Shea J.J., Powers G.C., and Urba W.J. Alterations in T cell receptor and signal transduction molecules in melanoma patients. Clin. Cancer Res. 1 (1995) 1327
10. Zea A.H., Rodriguez P.C., Culotta K.S., Hernandez C.P., DeSalvo J., Ochoa J.B., Park H.J., Zabaleta J., and Ochoa A.C. L-Arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes. Cell. Immunol. 232 (2004) 21
11. Zea A.H., Rodriguez P.C., Atkins M.B., Hernandez C., Signoretti S., Zabaleta J., McDermott D., Quiceno D., Youmans A., O'Neill A., Mier J., and Ochoa A.C. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res. 65 (2005) 3044